Chester County News and Community Website
Do you love keeping track of what’s going on in Chester County? Put your knowledge and expertise to use as a MyChesCo community contributor. Learn more >>
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has issued a warning letter to StubHub Holdings, Inc., alleging that the ticket resale giant failed to comply with the recently implemented …
FTC Cracks Down on StubHub: Hidden Fees Could Cost Millions! Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) has expanded its D2TO35 series of surface-mount thick film power resistors with the introduction of the D2TO35H. The new Automotive Grade device …
Vishay Intertechnology Unveils Automotive-Grade Resistor with Enhanced Pulse Absorption Read More
WASHINGTON, D.C. — Provisional data released by the CDC’s National Center for Injury Prevention and Control indicate a nearly 27% decline in predicted drug overdose deaths in 2024 compared to …
America’s Turning Point: 27% Drop in Overdose Deaths Saves Thousands in 2024 Read More
WILMINGTON, DE — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (OTC: ONFOP) invites investors, advisors, and analysts to join its live presentation at the Emerging Growth Conference on May 22, 2025.
Join Onfolio’s Live CEO Presentation at the Emerging Growth Conference – May 22, 2025! Read More
WASHINGTON, D.C. — The Internal Revenue Service (IRS) has announced that applications are now open for the Tax Counseling for the Elderly (TCE) and Volunteer Income Tax Assistance (VITA) grant …
IRS Opens Grants to Boost Free Tax Help for Seniors and Underserved Groups Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS), a key player in advancing treatments for chronic hepatitis B (cHBV), outlined its progress in Q1 2025, showcasing pivotal clinical milestones, financial …
Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) unveiled significant progress in its efforts to combat neurodegenerative diseases with updates on its pivotal Phase 3 clinical trial and solid financial …
Annovis Bio Advances Phase 3 Alzheimer’s Trial Amid Steady Financial Progress Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) announced substantial financial gains for the first quarter ending March 31, 2025, with revenue reaching $2.81 million. This marks a 121% increase year-over-year …
NEXGEL Reports 121% Revenue Growth in Q1 2025, Highlights Strong Momentum Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced significant progress in the first quarter of 2025, reporting $3.4 million in revenue from YCANTH. This figure reflects a …
Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline Read More
BERWYN, PA — AscellaHealth has earned a spot on the prestigious Financial Times list of The Americas’ Fastest Growing Companies 2025, a ranking compiled in collaboration with Statista Inc. The …
AscellaHealth Recognized Among Americas’ Fastest Growing Companies for 2025 Read More